BRIEF published on 12/01/2025 at 17:45, 3 days 11 hours ago Mersen Secures Contract with U.S. Defense for Isostatic Graphite Supply Mersen Advanced Materials U.S. Defense Logistics Agency Defense Applications Isostatic Graphite
REGULATED PRESS RELEASE published on 12/01/2025 at 17:40, 3 days 11 hours ago Mersen selected by the U.S. Defense Logistics Agency to Supply isostatic graphite Mersen chosen by U.S. Defense Logistics Agency to provide isostatic synthetic graphite, demonstrating advanced capabilities and commitment to serving defense applications Mersen Advanced Materials Defense Logistics Agency DLA Isostatic Graphite
BRIEF published on 11/25/2025 at 17:45, 9 days 11 hours ago Mersen Announces 2026 Provisional Financial Calendar Mersen Financial Calendar Quiet Periods Sales Announcements 2026 Financial Reporting
REGULATED PRESS RELEASE published on 11/25/2025 at 17:40, 9 days 11 hours ago Mersen: 2026 provisional financial calendar Mersen announces its 2026 provisional financial calendar, including key dates for sales and results, showcasing its expertise in electrical power and advanced materials Mersen Advanced Materials Financial Calendar Global Expert Electrical Power
BRIEF published on 11/13/2025 at 17:45, 21 days 11 hours ago Mersen to Supply Advanced Fuses to CATL Renewable Energy Mersen Battery Systems CATL Fuses
REGULATED PRESS RELEASE published on 11/13/2025 at 17:40, 21 days 11 hours ago Mersen selected by CATL to supply advanced fuses for battery systems Mersen selected by CATL to supply advanced fuses for battery systems. Partnership showcases Mersen's expertise in electrical power and commitment to driving electrification and renewable energy Renewable Energy Mersen Electrical Power CATL Advanced Fuses
BRIEF published on 11/05/2025 at 15:08, 29 days 14 hours ago Mersen Announces Share and Voting Rights Count as of October 31, 2025 Euronext Paris Voting Rights Shares Mersen October 2025
REGULATED PRESS RELEASE published on 11/05/2025 at 15:03, 29 days 14 hours ago Mersen: Number of shares and voting rights as of October 31, 2025 Mersen discloses total voting rights and shares in accordance with French regulations. 24,418,312 shares with 27,036,755 real voting rights as of October 31, 2025 Euronext Paris Voting Rights Shares French Regulations Mersen
BRIEF published on 10/23/2025 at 17:45, 1 month 12 days ago Mersen Reports Nine-Month 2025 Sales of €895 Million Amid Market Challenges Revenue Decline 2025 Guidance Electrical Power Growth Advanced Materials Downturn Market Forecasts
REGULATED PRESS RELEASE published on 10/23/2025 at 17:40, 1 month 12 days ago Mersen: nine-month 2025 sales of €895 million in a contrasting global market environment Mersen reports nine-month 2025 sales of €895 million, down 4.1% organically. Expectations for full-year 2025 revised to -5% to -3% organic sales growth and 16% EBITDA margin Mersen EBITDA Margin Organic Growth Financial Forecast 2025 Sales
Published on 12/05/2025 at 02:35, 2 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
